Literature DB >> 23910406

L-carnitine consumption, its metabolism by intestinal microbiota, and cardiovascular health.

Mark F McCarty1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23910406     DOI： 10.1016/j.mayocp.2013.06.004

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  4 in total

1.  Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance.

Authors:  James J DiNicolantonio; Mark McCarty; James OKeefe
Journal:  Open Heart       Date:  2019-02-27

2.  Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial.

Authors:  Bor-Jen Lee; Jun-Shuo Lin; Yi-Chin Lin; Ping-Ting Lin
Journal:  Nutr J       Date:  2014-08-04       Impact factor: 3.271

Review 3.  The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.

Authors:  Estefania Sanchez-Rodriguez; Alejandro Egea-Zorrilla; Julio Plaza-Díaz; Jerónimo Aragón-Vela; Sergio Muñoz-Quezada; Luis Tercedor-Sánchez; Francisco Abadia-Molina
Journal:  Nutrients       Date:  2020-02-26       Impact factor: 5.717

Review 4.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.